fluphenazine has been researched along with Catatonic Rigidity in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to find out whether the classic neuroleptic fluphenazine is a good model compound for inducing parkinsonian-like muscle rigidity in rats." | 7.70 | Muscle rigidity induced by fluphenazine in rats is antagonized by L-DOPA, an antiparkinsonian drug. ( Coper, H; Konieczny, J; Lorenc-Koci, E; Ossowska, K; Schulze, G; Wolfarth, S, 1998) |
| "A paranoid schizophrenic patient developed the neuroleptic malignant syndrome after receiving three doses of fluphenazine HCl and two doses of thioridazine while he was recovering from major trauma." | 7.66 | A case of neuroleptic malignant syndrome successfully treated with amantadine. ( Boettger, ML; McCarron, MM; Peck, JJ, 1982) |
| "Treatment with olanzapine moderately decreased, while treatment with fluphenazine significantly increased plasma cortisol levels and muscle rigidity." | 6.73 | The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study. ( Jakovljevic, M; Ljubicic, D; Marcinko, D; Mihaljevic-Peles, A; Muck-Seler, D; Mustapic, M; Pivac, N; Relja, M, 2007) |
| "The aim of the present study was to find out whether the classic neuroleptic fluphenazine is a good model compound for inducing parkinsonian-like muscle rigidity in rats." | 3.70 | Muscle rigidity induced by fluphenazine in rats is antagonized by L-DOPA, an antiparkinsonian drug. ( Coper, H; Konieczny, J; Lorenc-Koci, E; Ossowska, K; Schulze, G; Wolfarth, S, 1998) |
| "A paranoid schizophrenic patient developed the neuroleptic malignant syndrome after receiving three doses of fluphenazine HCl and two doses of thioridazine while he was recovering from major trauma." | 3.66 | A case of neuroleptic malignant syndrome successfully treated with amantadine. ( Boettger, ML; McCarron, MM; Peck, JJ, 1982) |
| "Treatment with olanzapine moderately decreased, while treatment with fluphenazine significantly increased plasma cortisol levels and muscle rigidity." | 2.73 | The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study. ( Jakovljevic, M; Ljubicic, D; Marcinko, D; Mihaljevic-Peles, A; Muck-Seler, D; Mustapic, M; Pivac, N; Relja, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Putzhammer, A | 1 |
| Perfahl, M | 1 |
| Pfeiff, L | 1 |
| Broll, K | 1 |
| Hess, L | 1 |
| Ibach, B | 1 |
| Jakovljevic, M | 1 |
| Pivac, N | 1 |
| Mihaljevic-Peles, A | 1 |
| Mustapic, M | 1 |
| Relja, M | 1 |
| Ljubicic, D | 1 |
| Marcinko, D | 1 |
| Muck-Seler, D | 1 |
| Schrader, G | 1 |
| Wong, C | 1 |
| Russell, R | 1 |
| Goldney, RD | 1 |
| Knezevic, W | 1 |
| Mastaglia, FL | 1 |
| Lefroy, RB | 1 |
| Fisher, A | 1 |
| Zubenko, G | 1 |
| Pope, HG | 1 |
| Pirovino, M | 1 |
| Meier, J | 1 |
| Meyer, M | 1 |
| Waldmeier, P | 1 |
| Schmid, M | 1 |
| McCarron, MM | 1 |
| Boettger, ML | 1 |
| Peck, JJ | 1 |
| Ossowska, K | 1 |
| Konieczny, J | 1 |
| Lorenc-Koci, E | 1 |
| Schulze, G | 1 |
| Coper, H | 1 |
| Wolfarth, S | 1 |
| Fabre, S | 1 |
| Gervais, C | 1 |
| Manuel, C | 1 |
| Vic Dupont, V | 1 |
| Meltzer, HY | 1 |
2 trials available for fluphenazine and Catatonic Rigidity
| Article | Year |
|---|---|
[Alterations of gait parameters under external cueing in schizophrenic patients: a switch study].
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Exercise Test; Femal | 2004 |
The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Female; Flu | 2007 |
8 other studies available for fluphenazine and Catatonic Rigidity
| Article | Year |
|---|---|
The neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Cognition Disorders; Consciousness Disorders; Fever; Fluphenazine; Humans; Mal | 1981 |
Neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Female; Fever; Fluphenazine; Haloperidol; Humans; Male | 1984 |
Management of a case of neuroleptic malignant syndrome with bromocriptine.
Topics: Adult; Antiparkinson Agents; Autonomic Nervous System Diseases; Bromocriptine; Fever; Fluphenazine; | 1983 |
[Malignant neuroleptics syndrome].
Topics: Adult; Amantadine; Baclofen; Cerebrospinal Fluid; Chromatography, Liquid; Cognition Disorders; Femal | 1984 |
A case of neuroleptic malignant syndrome successfully treated with amantadine.
Topics: Adult; Amantadine; Consciousness Disorders; Fluphenazine; Humans; Male; Malignant Hyperthermia; Musc | 1982 |
Muscle rigidity induced by fluphenazine in rats is antagonized by L-DOPA, an antiparkinsonian drug.
Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Dopamine Antagonists; Female; Fluphenazine; Lev | 1998 |
[Toxic syndrome induced by neuroleptics: report of 7 cases].
Topics: Adult; Female; Fluphenazine; Humans; Male; Malignant Hyperthermia; Middle Aged; Muscle Rigidity; Syn | 1977 |
Rigidity, hyperpyrexia and coma following fluphenazine enanthate.
Topics: Adult; Basal Ganglia Diseases; Benztropine; Catatonia; Coma; Creatine Kinase; Female; Fever; Fluphen | 1973 |